INHIBITION OF IN VITRO IMMUNOGLOBULIN PRODUCTION BY RAPAMYCIN1

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Transplantation

• Publication date

  1992-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-199205000-00019PMID 1585470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.

  1991cited by this paper
• Reversal of ongoing rejection of allografts by rapamycin.

  1991cited by this paper
• Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

  1990cited by this paper
• 1,25(OH)2 vitamin D3 inhibits the CD23 gene expression by human peripheral blood monocytes.

  1990cited by this paper
• CYCLOSPORINE, FK506, AND RAPAMYCIN: SOME EFFECTS ON EARLY ACTIVATION EVENTS IN SERUM‐FREE, MITOGEN‐STIMULATED MOUSE SPLEEN CELLS

  1990cited by this paper
• Suppression of B cell activation by cyclosporin A, FK506 and rapamycin

  1990cited by this paper
• Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.

  1990cited by this paper
• Rapamycin for immunosuppression in organ allografting.

  1989cited by this paper
• Recombinant interleukin (IL) 2‐induced human B cell differentiation is mediated by autocrine IL6

  1989cited by this paper
• Pleiotropy and redundancy: T cell-derived lymphokines in the immune response.

  1989cited by this paper
• The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

  1989cited by this paper
• A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase

  1989cited by this paper
• The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells

  1988cited by this paper
• IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

  1988cited by this paper
• Preexposure of resting B cells to interferon-gamma enhances their proliferative response to subsequent activation signals.

  1987cited by this paper
• The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.

  1987cited by this paper
• Two independent pathways of helper activity provided by a single T cell clone.

  1986cited by this paper
• Demonstration of intracytoplasmic IgE in circulating lymphocytes of allergic individuals.

  1985cited by this paper
• Activity of rapamycin (AY-22,989) against transplanted tumors.

  1984cited by this paper
• In vitro synthesis of IgE by human lymphocytes. III. IgE-potentiating activity of culture supernatants from Epstein-Barr virus (EBV) transformed B cells.

  1984cited by this paper
• The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man.

  1983cited by this paper
• Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation.

  1978cited by this paper
• Inhibition of the immune response by rapamycin, a new antifungal antibiotic.

  1977cited by this paper
• In vitro immune response of human peripheral lymphocytes. I. The mechanism(s) involved in T cell helper functions in the pokeweed mitogen-induced differentiation and proliferation of B cells.

  1977cited by this paper
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.

  1975cited by this paper

• Incidence and risk factors of de novo hepatitis E virus infection after receiving liver transplantation

  2024cites this paper
• Hepatitis E virus: from innate sensing to adaptive immune responses

  2024cites this paper
• Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus

  2023cites this paper
• Immunomodulatory Effects of Tulathromycin in Rabbits

  2017cites this paper
• Rapamycin, a specific inhibitor of the target of rapamycin complex 1, disrupts intestinal barrier integrity in broiler chicks.

  2016cites this paper
• Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

  2016cites this paper
• The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis

  2015cites this paper
• Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.

  2015cites this paper
• Rapamycin Represses Myotube Hypertrophy and Preserves Viability of C2C12 Cells During Myogenesis In Vitro

  2014cites this paper
• EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria

  2013cites this paper
• TNF FAMILY MEMBER MOUSE T CELLS RECEIVE COSTIMULATORY SIGNALS FROM LIGHT, A

  2013cites this paper
• Hepatitis E Virus Infection without Reactivation in Solid-Organ Transplant Recipients, France

  2011cites this paper
• [Hepatitis E infection in dialysis and after transplantation].

  2010cites this paper
• Use of rapamycin in the induction of tolerogenic dendritic cells.

  2009cites this paper
• Hepatitis E virus and chronic hepatitis in organ-transplant recipients.

  2008cites this paper
• Fetal Isoform of Human Retinoic Acid Receptor/3 Expressed in Small Cell Lung Cancer Lines 1

  2007cites this paper
• Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.

  2006cites this paper
• Desensitization protocols improving access and outcome in transplantation

  2005cites this paper
• Tuberous Sclerosis Complex: mutations, functions and phenotypes

  2005cites this paper
• Risk Factors for Capillary C4d Deposition in Kidney Allografts: Evaluation of a Large Study Cohort

  2004cites this paper
• Dipeptide Boronic Acid, a Novel Proteasome Inhibitor, Prevents Islet-Allograft Rejection

  2004cites this paper
• EphB6-null mutation results in compromised T cell function.

  2004cites this paper
• EphB 6-null mutation results in compromised T cell function

  2004cites this paper
• Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols

  2004cites this paper
• EphrinB1 Is Essential in T-cell-T-cell Co-operation during T-cell Activation*

  2004cites this paper
• Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival.

  2003cites this paper
• Relationship of donor-specific class-I anti-HLA antibodies detected by ELISA after kidney transplantation on the development of acute rejection and graft survival

  2003cites this paper
• Mouse EphrinB3 Augments T-cell Signaling and Responses to T-cell Receptor Ligation*

  2003cites this paper
• Sirolimus: a current perspective.

  2003cites this paper
• Ephrin B2 Induces T Cell Costimulation1

  2003cites this paper
• Ephrin B2 Induces T Cell Costimulation

  2003cites this paper
• EphB6 crosslinking results in costimulation of T cells.

  2002cites this paper
• A TNF Family Member LIGHT Transduces Costimulatory Signals into Human T Cells1

  2002cites this paper
• This information is current as Costimulatory Signals into Human T Cells A TNF Family Member LIGHT Transduces

  2002cites this paper
• Mouse T cells receive costimulatory signals from LIGHT, a TNF family member.

  2002cites this paper
• Transduction and Apoptosis in Jurkat Cells Cross-Linking of EphB6 Resulting in Signal

  2001cites this paper
• Cross-Linking of EphB6 Resulting in Signal Transduction and Apoptosis in Jurkat Cells1

  2001cites this paper
• SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1

  2001cites this paper
• Proteasome activity is required for T lymphocyte aggregation after mitogen activation

  2001cites this paper
• Immunosuppression in Liver Transplantation

  2000cites this paper
• The proteasome controls the expression of a proliferation‐associated nuclear antigen Ki‐67

  2000cites this paper
• Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus.

  2000cites this paper
• Modern immunosuppression.

  2000cites this paper
• Kinase targets in inflammation

  1999cites this paper
• Cyclosporine/tacrolimus (FK-506)

  1998cites this paper
• Role of proteasomes in T cell activation and proliferation.

  1998cites this paper
• Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey.

  1998cites this paper
• Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.

  1998cites this paper
• Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.

  1998cites this paper
• Glucocorticoids inhibit human antigen‐specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro

  1997cites this paper
• Pharmacologic Immunosuppressants in Xenotransplantation

  1997cites this paper
• Rapamycin inhibits aldolase A expression during human lymphocyte activation

  1996cites this paper
• Molecular cloning of the cDNA of mouse mitochondrial NADP‐dependent isocitrate dehydrogenase and the expression of the gene during lymphocyte activation

  1996cites this paper
• Mechanism of action of rapamycin (Sirolimus, Rapamune).

  1996cites this paper
• The immunosuppressive effect of rapamycin on mouse small bowel transplantation.

  1996cites this paper
• Expression of human mitochondrial NADP‐dependent isocitrate dehydrogenase during lymphocyte activation

  1996cites this paper
• [Perspectives of immunosuppressive therapy].

  1996cites this paper
• An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis.

  1996cites this paper
• Identification of porcine membrane antigens involved in the cytotoxic response mediated by human xenoreactive antibodies

  1996cites this paper
• Successful myoblast allotransplantation in mdx mice using rapamycin.

  1995cites this paper
• RAPAMYCIN GRAFT PRETREATMENT IN SMALL BOWEL AND KIDNEY TRANSPLANTATION IN THE RAT

  1995cites this paper
• The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft‐versus‐host response—an in vivo model of Th2‐like activity

  1995cites this paper
• Rapamycin: Distribution, Pharmacokinetics, and Therapeutic Range Investigations

  1995cites this paper
• Mechanism of action of the immunosuppressant rapamycin.

  1995cites this paper
• Rapamycin-induced long-term allograft survival depends on persistence of alloantigen.

  1994cites this paper
• Expression of a G-protein beta subunit-related gene during lymphocyte activation.

  1994cites this paper
• Effect of rapamycin on rat aortic ring vasomotion.

  1994cites this paper
• Rapamycin: A novel immunosuppressive macrolide

  1994cites this paper
• Fetal isoform of human retinoic acid receptor beta expressed in small cell lung cancer lines.

  1994cites this paper
• Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts.

  1994cites this paper
• The effect of rapamycin on T cell development in mice

  1994cites this paper
• Clinical use of immunosuppressants in transplantation

  1994cites this paper
• Rapamycin: Biological and therapeutic effects, binding by immunophilins and molecular targets of action

  1994cites this paper
• The expanding repertoire of therapeutic antirejection molecules.

  1994cites this paper
• Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells

  1994cites this paper
• Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin.

  1994cites this paper
• ABROGATION BY RAPAMYCIN OF ACCELERATED REJECTION IN SENSITIZED RATS BY INHIBITION OF ALLOANTIBODY RESPONSES AND SELECTIVE SUPPRESSION OF INTRAGRAFT MONONUCLEAR AND ENDOTHELIAL CELL ACTIVATION, CYTOKINE PRODUCTION, AND CELL ADHESION1,2

  1994cites this paper
• Blood distribution of rapamycin.

  1993cites this paper
• Immunosuppressive Profile of Rapamycin

  1993cites this paper
• Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.

  1993cites this paper
• Therapeutic drug monitoring (immunosuppressive drugs).

  1993cites this paper
• Anti‐CD28 antibody‐ and IL‐4‐induced human T cell proliferation is sensitive to rapamycin

  1993cites this paper
• RESPONSIVENESS OF PREACTIVATED B CELLS TO IL‐2 AND IL‐6 EFFECT OF CYCLOSPORINE AND RAPAMYCIN

  1993cites this paper
• Rapamycin's long-term effects on humoral and cellular immune responses in the rat.

  1993cites this paper
• New Immunosuppressive Drugs: Mechanistic Insights and Potential Therapeutic Advances

  1993cites this paper
• The effect of rapamycin on c-jun expression in human lymphocytes.

  1993cites this paper
• Therapeutic Monitoring of Rapamycin: A New Immunosuppressive Drug

  1993cites this paper
• Rapamycin: In Vitro Profile of a New Immunosuppressive Macrolide.

  1993cites this paper
• REVERSAL OF ONGOING HEART, KIDNEY, AND PANCREAS ALLOGRAFT REJECTION AND SUPPRESSION OF ACCELERATED HEART ALLOGRAFT REJECTION IN THE RAT BY RAPAMYCIN

  1993cites this paper
• Effects of rapamycin on human HLA-unrestricted cell killing.

  1992cites this paper
• ProliferationRole of Proteasomes in T Cell Activation and

  year unknowncites this paper